AbbVie
ABBV
#29
Rank
C$671.54 B
Marketcap
C$380.02
Share price
-1.69%
Change (1 day)
16.96%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2026 (TTM): C$12.16 Billion

According to AbbVie's latest financial reports the company's current earnings are C$64.38 Billion. In 2025 the company made an earning of C$9.39 Billion, an increase over its 2024 earnings that were of C$5.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$12.16 B29.5%
2025 C$9.39 B77.53%
2024 C$5.29 B-40.54%
2023 C$8.90 B-53.62%
2022 C$19.19 B3.76%
2021 C$18.50 B282.25%
2020 C$4.84 B-59.67%
2019 C$12.00 B62.13%
2018 C$7.40 B-32.74%
2017 C$11.00 B-1.99%
2016 C$11.23 B18.65%
2015 C$9.46 B180.5%
2014 C$3.37 B-55.57%
2013 C$7.59 B-6.86%
2012 C$8.15 B56.05%
2011 C$5.22 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$9.83 B-20.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$47.85 B 286.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.65 B 18.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$1.44 B-88.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-C$2.79 Billion-122.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.96 B 36.91%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$20.41 B 64.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$11.23 B-9.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$1.16 B-90.59%๐Ÿ‡บ๐Ÿ‡ธ USA